PETER TRINH: Open Payments
NPI 1831668508 · LONG BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$353 in 3 payments from 3 companies in 2025. Trend: 2023 $1,972 · 2024 $1,145 · 2025 $353
Food & beverage: $353
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $142 |
| AstraZeneca Pharmaceuticals LP | 1 | $120 |
| Gilead Sciences, Inc. | 1 | $92 |
Products named: TREMFYA, LOKELMA, Vemlidy.
Industry payments across CA — which companies pay providers there.
